Overview

Location [1]
3q25.32
Protein [2]
Myeloid leukemia factor 1
Synonyms [1]
-

Myeloid leukemia factor 1 (MLF1) is a gene that encodes a protein that functions in the phenotypic determination of hemopoietic cells. Fusions and nonsense mutations are observed in cancers such as intestinal cancer.

MLF1 is altered in 0.12% of all cancers with high grade ovarian serous adenocarcinoma, appendix signet ring cell carcinoma, breast invasive ductal carcinoma, colon adenocarcinoma, and endometrial serous adenocarcinoma having the greatest prevalence of alterations [3].

MLF1 GENIE Cases - Top Diseases

The most common alterations in MLF1 are MLF1 V98M (0.28%), MLF1 G260C (0.22%), MLF1 H245Q (0.39%), MLF1 R131C (0.39%), and MLF1 R27* (3.85%) [3].

MLF1 GENIE Cases - Top Alterations

Significance of MLF1 in Diseases

Myelodysplastic Syndromes +

Acute Myeloid Leukemia +

Chronic Myelomonocytic Leukemia +

Acute Lymphoblastic Leukemia +

Malignant Solid Tumor +

Chronic Myeloid Leukemia +

Prostate Adenocarcinoma +

Hodgkin Lymphoma +

Multiple Myeloma +

Non-Hodgkin Lymphoma +

Mantle Cell Lymphoma +

Prostate Carcinoma +

Refractory Anemia With Excess Blasts +

Acute Leukemia +

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome +

Anaplastic Large Cell Lymphoma +

Burkitt Lymphoma +

Follicular Lymphoma +

Marginal Zone Lymphoma +

Myelofibrosis +

Breast Carcinoma +

Ovarian Carcinoma +

Acute Biphenotypic Leukemia +

Chronic Lymphocytic Leukemia +

Mixed Phenotype Acute Leukemia +

Myelodysplastic/Myeloproliferative Neoplasm +

Myeloproliferative Neoplasm +

Colorectal Carcinoma +

B-Cell Non-Hodgkin Lymphoma +

Cervical Carcinoma +

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma +

Lymphoplasmacytic Lymphoma +

Primary Peritoneal Carcinoma +

Secondary Myelodysplastic Syndrome +

Therapy-Related Acute Myeloid Leukemia +

Therapy-Related Myelodysplastic Syndrome +

Head And Neck Squamous Cell Carcinoma +

Non-Small Cell Lung Carcinoma +

Endometrial Carcinoma +

Acute Undifferentiated Leukemia +

Adenocarcinoma Of The Gastroesophageal Junction +

B-Cell Acute Lymphoblastic Leukemia +

Blastic Plasmacytoid Dendritic Cell Neoplasm +

Chronic Myelomonocytic Leukemia-1 +

Diffuse Large B-Cell Lymphoma +

Fallopian Tube Carcinoma +

Lymphoblastic Lymphoma +

Lymphoma +

Mature T-Cell And NK-Cell Neoplasm +

Myelodysplastic Syndrome With Excess Blasts-2 +

Plasma Cell Leukemia +

Prolymphocytic Leukemia +

Secondary Acute Myeloid Leukemia +

Gastric Carcinoma +

Malignant Gastric Neoplasm +

Malignant Esophagogastric Neoplasm +

Malignant Intestinal Neoplasm +

High Grade Ovarian Serous Adenocarcinoma +

Malignant Ovarian Epithelial Tumor +

Soft Tissue Sarcoma +

Acute Bilineal Leukemia +

Acute Myeloid Leukemia With Myelodysplasia-Related Changes +

Acute Promyelocytic Leukemia +

Aggressive Non-Hodgkin Lymphoma +

Ampulla Of Vater Carcinoma +

Anal Carcinoma +

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative +

B-Cell Prolymphocytic Leukemia +

Bladder Urothelial Carcinoma +

Cholangiocarcinoma +

Chronic Myelomonocytic Leukemia-0 +

Chronic Myelomonocytic Leukemia-2 +

Esophageal Carcinoma +

Gastrointestinal Stromal Tumor +

Hematopoietic And Lymphoid Malignancy +

Histiocytic And Dendritic Cell Neoplasm +

Malignant Small Intestinal Neoplasm +

Mature B-Cell Lymphoma/Leukemia +

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma +

Mediastinal Large B-Cell Lymphoma +

Myelodysplastic Syndrome With Excess Blasts-1 +

NK-Cell Lymphoma, Unclassifiable +

Pancreatic Adenocarcinoma +

Pancreatic Carcinoma +

Penile Carcinoma +

Primary Myelofibrosis +

Refractory Anemia +

Refractory Anemia With Ring Sideroblasts +

Richter Syndrome +

Small Cell Lung Carcinoma +

Small Lymphocytic Leukemia +

Systemic Mastocytosis +

T-Cell Acute Lymphoblastic Leukemia +

T-Cell Lymphoblastic Leukemia/Lymphoma +

T-Cell Non-Hodgkin Lymphoma +

T-Cell And NK-Cell Neoplasm +

Therapy-Related Myeloid Neoplasm +

Urothelial Carcinoma +

Vaginal Carcinoma +

Vulvar Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.